Meteospasmyl

Alverine citrate and Simethicone, the active ingredients in Meteospasmyl, are antispasmodic and antiflatulent agents presented as an oral combination for adult use. They relieve abdominal cramping, bloating and flatulence associated with functional gastrointestinal disorders such as irritable bowel syndrome.

GNH USA supplies Meteospasmyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meteospasmyl is used to manage functional gastrointestinal disorders by reducing smooth‑muscle spasm and facilitating gas elimination.

Abdominal pain and cramping (IBS): alleviates painful spasms and improves bowel comfort. Bloating and flatulence: reduces trapped gas and associated discomfort. Functional gastrointestinal disorders: provides overall symptom relief in conditions such as irritable bowel syndrome.

Meteospasmyl may cause adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects: - Nausea: mild stomach upset may occur. - Headache: transient headache reported. - Dizziness: occasional light‑headedness. - Dry mouth: reduced salivation. - Abdominal discomfort: mild pain or irritation. - Diarrhoea: loose stools in some patients.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling or hives. - Angioedema: swelling of face, lips or throat. - Severe abdominal pain: persistent or worsening pain. - Persistent vomiting: inability to retain fluids. - Anaphylaxis: rare life‑threatening hypersensitivity. - Hepatic dysfunction: abnormal liver enzymes (very rare).

Before using Meteospasmyl, consider the following precautions to ensure safe and effective therapy. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: caution advised as excretion in milk is unknown. - Renal or hepatic impairment: use with clinical monitoring. - Known hypersensitivity: discontinue if allergic reaction occurs. - Concomitant anticholinergic drugs: may increase anticholinergic effects; monitor. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Meteospasmyl can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Other antispasmodic agents: additive smooth‑muscle relaxation may cause excessive GI motility suppression. - Monoamine oxidase inhibitors (MAOIs): combined use may lead to hypotensive episodes.

Moderate Interactions (Monitor Closely): - Antacids: may alter alverine absorption; monitor therapeutic effect. - Diuretics: concurrent use can affect electrolyte balance; observe patient status. - Alcohol: may enhance dizziness or drowsiness; advise moderation.